Copyright Reports & Markets. All rights reserved.

Global Iopromide Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Iopromide Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 150 mg I/mL
    • 1.3.3 240 mg I/mL
    • 1.3.4 300 mg I/mL
    • 1.3.5 370 mg I/mL
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Iopromide Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 CT
    • 1.4.3 Digital Subtraction Angiography
    • 1.4.4 Other
  • 1.5 Global Iopromide Injection Market Size & Forecast
    • 1.5.1 Global Iopromide Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Iopromide Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Iopromide Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Bayer HealthCare
    • 2.1.1 Bayer HealthCare Details
    • 2.1.2 Bayer HealthCare Major Business
    • 2.1.3 Bayer HealthCare Iopromide Injection Product and Services
    • 2.1.4 Bayer HealthCare Iopromide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bayer HealthCare Recent Developments/Updates
  • 2.2 Brilliant Pharmaceutical
    • 2.2.1 Brilliant Pharmaceutical Details
    • 2.2.2 Brilliant Pharmaceutical Major Business
    • 2.2.3 Brilliant Pharmaceutical Iopromide Injection Product and Services
    • 2.2.4 Brilliant Pharmaceutical Iopromide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Brilliant Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Iopromide Injection by Manufacturer

  • 3.1 Global Iopromide Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Iopromide Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Iopromide Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Iopromide Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Iopromide Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Iopromide Injection Manufacturer Market Share in 2025
  • 3.5 Iopromide Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Iopromide Injection Market: Region Footprint
    • 3.5.2 Iopromide Injection Market: Company Product Type Footprint
    • 3.5.3 Iopromide Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Iopromide Injection Market Size by Region
    • 4.1.1 Global Iopromide Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Iopromide Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Iopromide Injection Average Price by Region (2021-2032)
  • 4.2 North America Iopromide Injection Consumption Value (2021-2032)
  • 4.3 Europe Iopromide Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Iopromide Injection Consumption Value (2021-2032)
  • 4.5 South America Iopromide Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Iopromide Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Iopromide Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Iopromide Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Iopromide Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Iopromide Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Iopromide Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Iopromide Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Iopromide Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Iopromide Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Iopromide Injection Market Size by Country
    • 7.3.1 North America Iopromide Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Iopromide Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Iopromide Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Iopromide Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Iopromide Injection Market Size by Country
    • 8.3.1 Europe Iopromide Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Iopromide Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Iopromide Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Iopromide Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Iopromide Injection Market Size by Region
    • 9.3.1 Asia-Pacific Iopromide Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Iopromide Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Iopromide Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Iopromide Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Iopromide Injection Market Size by Country
    • 10.3.1 South America Iopromide Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Iopromide Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Iopromide Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Iopromide Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Iopromide Injection Market Size by Country
    • 11.3.1 Middle East & Africa Iopromide Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Iopromide Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Iopromide Injection Market Drivers
  • 12.2 Iopromide Injection Market Restraints
  • 12.3 Iopromide Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Iopromide Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Iopromide Injection
  • 13.3 Iopromide Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Iopromide Injection Typical Distributors
  • 14.3 Iopromide Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Iopromide Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Iopromide Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Iopromide Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Iopromide Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Iopromide Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Iopromide Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Iopromide Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Iopromide Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer HealthCare, Brilliant Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Iopromide Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    150 mg I/mL
    240 mg I/mL
    300 mg I/mL
    370 mg I/mL
    Market segment by Application
    CT
    Digital Subtraction Angiography
    Other
    Major players covered
    Bayer HealthCare
    Brilliant Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Iopromide Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Iopromide Injection, with price, sales quantity, revenue, and global market share of Iopromide Injection from 2021 to 2026.
    Chapter 3, the Iopromide Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Iopromide Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Iopromide Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Iopromide Injection.
    Chapter 14 and 15, to describe Iopromide Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now